Chih-Wei Tseng

12PUBLICATIONS
28CO-AUTHORS
AllergyExercise physiologyMolecular targetsRheumatology and arthritisAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 14, 2025
Survival benefit of tofacitinib in interstitial lung disease associated with anti-MDA5-positive dermatomyositis: a need for further validation.

Chih-Wei Tseng, James Cheng-Chung Wei

|Sep 17, 2024
Statin-associated muscle symptoms: A comprehensive exploration of epidemiology, pathophysiology, diagnosis, and clinical management strategies.

Meera Shah, Karun Shrestha, Chih-Wei Tseng

|Jun 04, 2024
Upfront combination therapy in anti-melanoma differentiation-associated gene 5 (MDA5) associated rapidly progressive interstitial lung disease.

Chih-Wei Tseng

|Mar 12, 2024
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.

Cristiana Sieiro Santos, Jun-Peng Chen, Elena Nikiphorou

|Sep 04, 2023
Other iatrogenic immunodeficiency-associated lymphoproliferative disorders in anti-melanoma differentiation-associated protein 5 associated myositis-Truly iatrogenic or primary immunodeficiency?

Chih-Wei Tseng, Latika Gupta

|Aug 30, 2023
Tofacitinib and pirfenidone as rescue therapies for severe COVID-19 in a patient with previously stable interstitial lung disease associated with Sjögren syndrome.

Yu-Chuan Tsao, Shih-Han Chuang, Chih-Wei Tseng

Pageof 2

Frequent Collaborators

4 joint publications

Yi-Ming Chen

3 joint publications

Latika Gupta

2 joint publications

Pin-Kuei Fu

2 joint publications

Tsai-Hung Yen